Overcoming antigen tolerance to develop GB22-45-2, an anti-DKK1 antibody for gastric cancer
{{output}}
Background: Gastric cancer (GC) represents one of the most prevalent and lethal malignancies, however, current treatments have shown limited efficacy. Clinical investigations have revealed that Dickkopf-1 (DKK1)-high GC patients ... ...
